Lead Product(s): GS030
Therapeutic Area: Ophthalmology
Highest Development Status: Phase I/ Phase II Product Type: Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 14, 2020
The DSMB confirmed the absence of any safety issues for the second cohort of three subjects in PIONEER Phase I/II clinical trial of GS030.